Author: Rachel Paul
Acoramidis Triumph: Safe & Effective in Transthyretin Amyloid Cardiomyopathy
The heart, which pumps over 100,000 times per day, is a vital muscle that transports.
Gabapentinoids and COPD Exacerbation
Explore the connection between Gabapentinoids and severe COPD exacerbation A population-based cohort study of almost.
AI’s Role in Personalized Hypertension Care
Researchers analyzed current breakthroughs in artificial intelligence (AI) technologies for treating hypertension (HTN) and associated.
COVID-19 and Atrial Fibrillation: Elevated Mortality Risk Unveiled
The frequency and prognosis of newly diagnosed atrial fibrillation (AF) in patients hospitalized with severe.
Cannabis for Chronic Pain: Increased Arrhythmia Risk?
According to a study published today (Thursday) in the European Heart Journal, people who use.
New Weapon Against PARP Inhibitor-Resistant Ovarian Cancers
On December 22, 2023, a new editorial piece titled “One more step toward treatment of.
Cardiac Care: Painless Arrhythmia with Injectable Hydrogel
A groundbreaking study led by Dr. Mehdi Razavi at The Texas Heart Institute (THI) in.
COVID-19 Defense: Antiviral Power with Plant-Based Diets
A plant-based or vegetarian diet is associated with a 39% decreased risk of COVID-19 infection,.
Rare Ginsenosides Pave the Way for Future Medicine
Researchers examined the structural and functional properties, traditional and modern applications, modes of action, toxicity,.
FDA Approves Berdazimer Gel: Breakthrough for Molluscum Contagiosum Treatment
Berdazimer gel 10.3% was approved by the Food and Drug Administration (FDA) on January 5.